Next Article in Journal
The Effect of Non-Overlapping Somatic Mutations in BRAF, NRAS, NF1, or CKIT on the Incidence and Outcome of Brain Metastases during Immune Checkpoint Inhibitor Therapy of Metastatic Melanoma
Next Article in Special Issue
Erdheim–Chester Disease: Investigating the Correlation between Targeted Treatment Therapy and Disease Outcomes
Previous Article in Journal
miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma
Previous Article in Special Issue
CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study
 
 
Article

Article Versions Notes

Cancers 2024, 16(3), 593; https://doi.org/10.3390/cancers16030593
Action Date Notes Link
article pdf uploaded. 30 January 2024 14:53 CET Version of Record https://www.mdpi.com/2072-6694/16/3/593/pdf-vor
article pdf uploaded. 30 January 2024 15:30 CET Updated version of record https://www.mdpi.com/2072-6694/16/3/593/pdf-vor
article pdf uploaded. 30 January 2024 15:47 CET Updated version of record https://www.mdpi.com/2072-6694/16/3/593/pdf-vor
article xml file uploaded 31 January 2024 04:12 CET Original file -
article xml uploaded. 31 January 2024 04:12 CET Update https://www.mdpi.com/2072-6694/16/3/593/xml
article pdf uploaded. 31 January 2024 04:13 CET Updated version of record https://www.mdpi.com/2072-6694/16/3/593/pdf
article html file updated 31 January 2024 04:14 CET Original file https://www.mdpi.com/2072-6694/16/3/593/html
Back to TopTop